TESTI

ORION CORPORATION PRESS RELEASE 23 JUNE 2026 at 9:30 EEST         Orion Pharma’s ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission Orion...

ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS18 June 2026 at 14.00 EEST                        Orion Corporation: Disclosure Under Chapter 9 Section 10 of the...